7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2016-09-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2011-09-30 
      
    		                                               
      cash flows from operating activities:
    		                                               
      net earnings
    		38,185,000 -17,678,000 22,588,000 34,890,000 33,600,000              45,403,000 46,143,000 33,395,000 58,845,000 36,433,000 119,620,000 14,398,000 16,460,000 44,654,000 17,555,000 17,403,000 41,701,000 19,739,000 48,429,000 16,281,000 30,291,000 25,852,000 22,707,000 26,329,000 23,907,000 26,824,000 31,641,000 25,055,000 27,428,000 28,411,000 33,118,000 25,364,000 25,668,000 27,521,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                               
      depreciation and amortization
    		24,340,000 27,111,000 27,571,000 27,084,000 28,137,000 28,057,000 27,311,000 27,803,000 28,540,000 26,923,000 26,971,000 26,703,000 26,641,000 25,866,000 25,367,000 25,102,000 24,734,000 24,672,000 21,103,000 20,884,000 21,088,000 20,991,000 21,108,000 20,553,000 20,085,000 19,919,000 19,322,000 19,878,000 19,052,000 17,152,000 16,273,000 17,394,000 13,644,000 10,828,000 10,590,000 10,685,000 9,499,000 8,559,000 5,311,000 4,918,000 4,856,000 4,090,000 3,042,000 3,001,000 3,173,000 3,105,000 3,135,000 
      deferred income taxes
    		5,275,000 -32,282,000 -5,408,000 -8,077,000 -5,340,000 -9,551,000 -7,582,000 -10,723,000 -11,591,000 -6,916,000 -16,286,000 -1,598,000 -4,767,000 -1,072,000 655,000 1,826,000 5,407,000 -21,408,000 -6,239,000 668,000 -452,000 4,489,000 -6,164,000 15,412,000 -607,000 -2,468,000 -2,008,000 -5,338,000 -3,768,000 1,314,000 -4,493,000 -42,367,000 -1,170,000 57,000 -321,000 -1,115,000 2,098,000 -1,617,000 1,245,000 -1,092,000 -1,677,000 -1,329,000 -480,000 -567,000 -710,000 -777,000 -1,066,000 
      stock-based compensation expense
    		11,682,000 4,550,000 11,391,000 14,708,000 10,184,000 7,063,000 8,133,000 12,753,000 10,093,000 -2,085,000 10,110,000 16,744,000 14,461,000 8,406,000 8,071,000 13,969,000 11,737,000 9,808,000 10,643,000 15,578,000 12,953,000 6,017,000 7,855,000 10,129,000 8,366,000 8,129,000 5,725,000 6,861,000 11,565,000 14,653,000 4,748,000 5,663,000 3,176,000 2,317,000 2,321,000 2,038,000 1,232,000 1,362,000 888,000 740,000 1,326,000 569,000 490,000 286,000 785,000 303,000 290,000 
      (gain) loss on equity method investment
    		-294,000 -1,107,000 589,000 -46,000 -374,000  1,747,000 1,913,000 2,382,000                                       
      (gain) loss on investments
    		-2,054,000                                               
      asset impairment restructuring
    		 11,351,000 120,000 3,802,000 6,039,000         0 0 0 546,000                               
      leases
    		-912,000 183,000 10,000 47,000 445,000 -124,000 636,000 583,000 613,000 625,000 794,000 -1,905,000 2,545,000 -227,000 -473,000 -422,000 -79,000 -8,000 -30,000                             
      recovery of assets held-for-sale
    		-6,789,000                                               
      other operating activity
    		1,001,000 148,000 222,000 -442,000 747,000 162,000 166,000 74,000 182,000 159,000 184,000 144,000 -32,000 119,000 166,000 -114,000 497,000 144,000 -932,000 129,000 195,000 -58,000 -866,000 28,000 164,000 70,000 -85,000 123,000 2,217,000 -888,000 108,000                 
      change in operating assets and operating liabilities, net of acquisition:
    		                                               
      trade accounts and other receivables
    		22,392,000 28,861,000 -15,669,000 -623,000 21,563,000 -17,922,000 -22,944,000 4,734,000 15,599,000 -92,000 -32,200,000 -5,910,000 17,335,000 3,334,000 -51,583,000 -5,710,000 -3,637,000 17,161,000 -30,383,000 -3,237,000 910,000 3,864,000 -7,258,000 11,355,000 -1,405,000    8,307,000 -12,099,000 -9,237,000 28,812,000 -10,176,000 -20,029,000 9,176,000 -3,763,000 -4,431,000 422,000 8,007,000 -9,753,000 2,997,000 -106,000 -15,000 -5,964,000 2,592,000 1,053,000 1,591,000 
      inventories
    		-14,002,000 -6,604,000 173,000 -8,908,000 -2,805,000 -4,616,000 -22,000 -4,361,000 -5,216,000 -1,351,000 -10,454,000 -7,677,000 -10,685,000 -15,973,000 -7,334,000 -5,719,000 -2,981,000 -3,025,000 -3,529,000 1,382,000 -1,968,000 -4,852,000 -5,628,000 -3,661,000 -720,000 -2,097,000 -3,338,000 -1,534,000 -6,678,000 -1,751,000 -4,063,000 -5,099,000 -2,414,000 322,000 -1,383,000 -3,176,000 168,000 -2,326,000 -2,191,000 539,000 -947,000 -296,000 -184,000 -670,000 -278,000 -1,084,000 -226,000 
      prepaid expenses
    		380,000 -7,155,000 -6,812,000 2,753,000 -3,158,000 -1,163,000 1,166,000 -577,000 -2,572,000 972,000 -3,552,000 755,000 -2,760,000 494,000 3,449,000 -1,173,000 -5,852,000         302,000 1,258,000   1,924,000 -463,000 716,000 605,000 464,000 -744,000 -766,000 -25,000 8,000 -516,000 -69,000 336,000 -305,000 207,000 -47,000 59,000 -252,000 -145,000 
      trade accounts payable, accrued expenses, contract liabilities, and other
    		-2,115,000 -13,315,000 -610,000 10,882,000 -10,911,000 18,609,000 1,778,000 8,077,000 -2,695,000 -2,261,000 5,894,000 -10,140,000 -1,401,000 1,512,000 11,404,000 2,128,000 -2,303,000  3,574,000 1,706,000 6,918,000  2,916,000 5,659,000 1,456,000                       
      salaries, wages and related accruals
    		-22,101,000 3,402,000 8,124,000 12,128,000 -8,246,000 5,455,000 11,468,000 -2,148,000 -2,157,000 -1,799,000 10,506,000 -4,905,000 -28,360,000 5,701,000 12,467,000 8,525,000 -18,933,000 6,707,000 15,542,000 9,767,000 -11,480,000 7,642,000 5,095,000 798,000 -10,983,000 5,115,000 3,835,000 4,539,000 -8,476,000 4,070,000 -4,613,000 7,711,000 -7,257,000 2,883,000 717,000 -1,704,000 986,000 2,528,000 -429,000 1,320,000 -1,277,000 1,420,000 -728,000 1,026,000 -790,000 400,000 825,000 
      income taxes payable
    		-27,403,000   -4,037,000 -6,180,000 -10,599,000 9,885,000 13,051,000 -22,936,000 -6,340,000 -9,587,000 10,496,000 2,939,000 11,875,000 -3,108,000 13,718,000 -19,818,000 9,898,000 -454,000 5,365,000 -1,383,000 -17,386,000 -2,231,000 11,153,000 1,233,000 -1,051,000 429,000 -4,034,000 -4,864,000 11,983,000 5,593,000 -10,222,000 2,850,000 1,794,000 -7,436,000 6,204,000 -967,000 1,127,000 -5,085,000 3,796,000 -741,000 91,000 -1,955,000 2,134,000 -234,000 -782,000 -1,449,000 
      net cash from operating activities
    		27,585,000 98,201,000 41,120,000 84,346,000 63,889,000 75,496,000 80,986,000 83,116,000 59,383,000 83,393,000 50,535,000 64,384,000 56,081,000 102,717,000 73,128,000 100,993,000 48,434,000 122,020,000 74,866,000 89,269,000 66,009,000 44,791,000 49,469,000 70,418,000 40,539,000 55,946,000 39,662,000 46,563,000 39,448,000 64,839,000 21,650,000 57,376,000 26,502,000 37,137,000 38,539,000 31,833,000 37,139,000 35,718,000 37,921,000 34,934,000 31,322,000 32,585,000 29,987,000 33,025,000 31,287,000 29,263,000 34,432,000 
      capex
    		-5,363,000 -4,890,000 -10,123,000 -6,821,000 -9,172,000 -17,980,000 -16,441,000 -14,864,000 -13,592,000 -10,831,000 -11,748,000 -6,109,000 -9,556,000 -13,570,000 -15,100,000 -10,168,000 -6,070,000 -11,316,000 -10,602,000 -11,445,000 -10,938,000 -17,373,000 -9,282,000 -14,564,000 -10,525,000 0 -4,925,000 0 -4,190,000 0 -3,508,000 0 -2,442,000 -2,836,000 -4,887,000 -6,121,000 -6,934,000 -4,905,000 -2,102,000 -4,261,000 -3,647,000 -3,811,000 -5,346,000 -6,373,000 -8,220,000 -2,515,000 -1,096,000 
      free cash flows
    		22,222,000 93,311,000 30,997,000 77,525,000 54,717,000 57,516,000 64,545,000 68,252,000 45,791,000 72,562,000 38,787,000 58,275,000 46,525,000 89,147,000 58,028,000 90,825,000 42,364,000 110,704,000 64,264,000 77,824,000 55,071,000 27,418,000 40,187,000 55,854,000 30,014,000 55,946,000 34,737,000 46,563,000 35,258,000 64,839,000 18,142,000 57,376,000 24,060,000 34,301,000 33,652,000 25,712,000 30,205,000 30,813,000 35,819,000 30,673,000 27,675,000 28,774,000 24,641,000 26,652,000 23,067,000 26,748,000 33,336,000 
      ​
    		                                               
      cash flows from investing activities:
    		                                               
      proceeds from sale of available-for-sale investments
    		 0 0 0 1,085,000 4,324,000 0 0 23,759,000                                       
      additions to property and equipment
    		-5,363,000 -4,890,000 -10,123,000 -6,821,000 -9,172,000 -17,980,000 -16,441,000 -14,864,000 -13,592,000 -10,831,000 -11,748,000 -6,109,000 -9,556,000 -13,570,000 -15,100,000 -10,168,000 -6,070,000 -11,316,000 -10,602,000 -11,445,000 -10,938,000 -17,373,000 -9,282,000 -14,564,000 -10,525,000    -4,190,000    -2,442,000 -2,836,000 -4,887,000 -6,121,000 -6,934,000 -4,905,000 -2,102,000 -4,261,000 -3,647,000 -3,811,000 -5,346,000 -6,373,000 -8,220,000 -2,515,000 -1,096,000 
      distributions from wilson wolf
    		1,351,000                                               
      investment in spear bio
    		 0 0 0 -15,000,000                                           
      proceeds from sale of assets held-for-sale
    		4,617,000 658,000 0                                             
      net cash from investing activities
    		605,000 406,000 -8,873,000 -5,032,000 -21,684,000 -8,808,000 -16,441,000 -23,671,000 -154,110,000 -4,756,000 -241,096,000 -109,000 -19,688,000 -18,570,000 -35,993,000   -226,903,000 129,000 -8,604,000 -8,138,000 -10,473,000 19,358,000 33,295,000 -15,085,000 -30,316,000 -4,736,000 -13,634,000 -288,113,000 37,968,000 -57,930,000 249,532,000 -268,282,000 -13,986,000 -4,805,000 -85,161,000 -5,522,000 -354,754,000 163,685,000 -81,000 -8,783,000 -105,133,000 -4,759,000 -11,525,000 -9,000,000 -5,920,000 -10,449,000 
      cash flows from financing activities:
    		                                               
      cash dividends
    		-12,444,000 -12,387,000 -12,580,000 -12,736,000 -12,688,000 -12,627,000 -12,579,000 -12,559,000 -12,654,000 -12,597,000 -12,582,000 -12,561,000 -12,545,000 -12,539,000 -12,577,000 -12,576,000 -12,493,000 -12,448,000 -12,446,000 -12,392,000 -12,336,000 -12,258,000 -12,279,000 -12,196,000 -12,169,000 -12,127,000 -12,086,000 -12,085,000 -12,066,000 -12,032,000 -11,995,000 -12,014,000 -11,932,000 -11,902,000 -11,902,000 -11,894,000 -11,888,000 -11,472,000 -11,469,000 -11,440,000 -11,434,000 -11,051,000 -11,050,000 -11,053,000 -11,048,000 -10,312,000 -10,026,000 
      proceeds from stock option exercises
    		23,495,000 6,226,000 14,872,000 5,540,000 25,101,000 22,934,000 18,331,000 5,276,000 14,394,000 8,414,000 4,422,000 5,027,000 11,950,000 8,809,000 11,846,000 18,620,000 37,880,000 10,100,000 22,655,000 16,919,000 15,418,000 32,493,000 11,243,000 18,295,000 8,952,000 10,921,000 8,169,000 2,407,000 16,453,000 5,446,000 7,025,000 4,673,000 2,026,000 748,000 47,000 1,128,000 -1,000 1,864,000 3,198,000 1,568,000 2,415,000 1,145,000 281,000 0 688,000 136,000 45,000 
      repurchases of common stock
    		-24,000                                               
      repayments of long-term debt
    		-46,000,000 -50,000,000 -8,000,000 0 -19,000,000 -70,000,000 -58,000,000 -58,000,000 -70,000,000 -20,000,000 0 -64,661,000 -441,000,000  -63,125,000 -58,125,000 -51,125,000  -16,125,000 -92,125,000 -33,125,000  -3,125,000 -103,125,000 -19,125,000    -357,125,000                   
      taxes paid on rsus and net share settlements
    		-9,231,000 -234,000 -291,000 -1,013,000 -4,984,000 -402,000 -168,000 -1,074,000 -20,228,000 -39,000 -11,001,000 0 -17,853,000                                   
      net cash from financing activities
    		-44,204,000 -90,452,000 -68,045,000 -83,837,000 -11,571,000 -60,095,000 -52,416,000 -81,399,000 71,512,000 -24,222,000 150,839,000 -72,195,000 -31,806,000 -65,728,000 -84,065,000 -53,376,000 -39,684,000 117,688,000 -55,227,000 -90,079,000 -34,933,000 -44,720,000 -17,786,000 -97,027,000 -24,269,000 -19,897,000 -27,043,000 -41,207,000 222,531,000 -62,832,000 -952,000 -277,738,000 242,334,000 -19,535,000 -13,366,000 41,865,000 -85,677,000 102,470,000 -8,009,000 -9,912,000 -8,983,000 -9,902,000 -12,584,000 -11,048,000 -10,297,000 -10,748,000 -21,556,000 
      effect of exchange rate changes on cash and cash equivalents
    		-1,210,000 13,361,000 -1,081,000 -5,468,000 5,115,000 5,283,000 -2,346,000 3,423,000 -8,693,000 -1,126,000 2,322,000 7,345,000 -11,897,000 -6,673,000 -4,094,000 3,075,000 -4,400,000 150,000 842,000 5,536,000 -159,000 811,000 -5,117,000 3,715,000 -2,180,000 -407,000 1,791,000 -510,000 -1,182,000 -4,593,000 2,382,000 -5,126,000 5,248,000 -355,000 -6,758,000 5,773,000 2,145,000 -3,763,000 1,368,000 260,000 990,000 2,520,000 429,000 -3,025,000 491,000 1,535,000 -805,000 
      net change in cash and cash equivalents
    		-17,224,000 21,516,000 -36,879,000 -9,991,000 35,749,000 11,876,000 9,783,000 -18,531,000 -31,908,000 53,289,000 -37,400,000 -575,000 -7,310,000 11,746,000 -51,024,000 15,524,000 -2,770,000                               
      cash and cash equivalents at beginning of period
    		162,186,000 0 0 0 151,791,000 0 0 0 180,571,000 0 0 0 172,567,000 0 0 0 199,091,000  0 0 146,625,000  0 0 100,886,000  0 0 121,990,000  0 27,375,000 64,237,000 0 0 54,532,000  318,568,000  0 0 163,786,000  0 0 116,675,000 77,613,000 
      cash and cash equivalents at end of period
    		144,962,000 21,516,000 -36,879,000 -9,991,000 187,540,000 11,876,000 9,783,000 -18,531,000 148,663,000 53,289,000 -37,400,000 -575,000 165,257,000 11,746,000 -51,024,000 15,524,000 196,321,000  20,610,000 -3,878,000 169,404,000  45,923,000 10,402,000 99,891,000  9,675,000 -8,788,000 94,674,000  -34,850,000 51,869,000 69,589,000 3,261,000 13,610,000 48,842,000  98,239,000  25,201,000 14,546,000 83,856,000  7,427,000 12,481,000 130,805,000 79,235,000 
      supplemental disclosure of cash flow information:
    		                                               
      cash paid for income taxes
    		30,812,000  18,306,000 21,103,000 16,490,000  7,201,000 4,848,000 32,797,000  36,172,000 11,519,000 14,892,000  7,597,000 3,298,000 12,070,000  6,950,000 4,973,000 6,034,000  17,814,000 4,585,000 2,452,000  7,502,000 10,688,000 8,447,000  3,230,000                 
      cash paid for interest
    		4,822,000  4,401,000 4,626,000 5,205,000  3,807,000 4,080,000 4,506,000  154,000 2,210,000 3,409,000  2,378,000 3,037,000 3,107,000  2,950,000 3,542,000 4,237,000  4,327,000 4,777,000 5,092,000  5,298,000 7,583,000 3,229,000  3,247,000                 
      costs recognized on sale of acquired inventory
    		 197,000 181,000 185,000 188,000 179,000 186,000 183,000 181,000 0 0 100,000 300,000 0 0 84,000 1,512,000 1,474,000 68,000       935,000 935,000 934,000 935,000 442,000 1,431,000 -3,637,000 4,219,000 1,082,000 1,244,000 1,113,000 1,709,000 3,167,000 3,168,000 1,177,000 1,404,000 1,731,000 1,005,000 1,032,000 1,200,000 1,264,000 2,148,000 
      fair value adjustment to contingent consideration payable
    		     0 0 -1,750,000 -1,750,000 -1,750,000 -1,750,000 -8,500,000 -100,000 200,000 -4,200,000 -13,600,000 -2,800,000 -888,000 1,588,000 4,750,000 -150,000 -300,000 -705,000 -600,000 700,000 -900,000 -400,000 -500,000 -200,000 0 200,000 18,000,000 1,900,000               
      gain on sale of ccxi investment
    		                                               
      gain on sale of eminence
    		         0 0 0 -11,682,000                                   
      impairment of assets held-for-sale
    		     15,925,000 0                                         
      income taxes receivable
    		 16,381,000                                              
      purchases of available-for-sale investments
    		     0 0   0 0 -6,000,000 -14,500,000 -5,000,000 -34,498,000 0 -13,500,000  -12,500,000 -945,000 -26,239,000  -25,629,000 -9,228,000 -15,871,000  -11,693,000 -14,306,000 -11,694,000  0                 
      proceeds from sale of ccxi investment
    		         0 0 0 73,219,000                                   
      acquisitions, net of cash acquired
    		     0 0 -3,281,000 -166,426,000 0 0 0 -101,184,000     -215,587,000 0       -17,206,000 1,000 -58,000 -272,229,000 -2,785,000 -54,422,000 248,360,000 -259,004,000 -8,000,000 82,000 -82,970,000 0 -360,175,000 -6,031,000         
      distributions from (investments in) wilson wolf
    		   0 1,403,000 4,848,000 0 0 2,149,000                                       
      proceeds from sale of eminence
    		         0 0 0 17,824,000                                   
      re-purchases of common stock
    		 -100,057,000 -100,046,000   0 0   0 0 0 -19,562,000 -58,818,000 -60,838,000           0 -1,000                     
      borrowings under line-of-credit agreement
    		 66,000,000    0 0 65,000,000 160,000,000 0 170,000,000 0 449,661,000 0 40,000,000 40,000,000 10,000,000             0 30,000,000 -318,500,000 343,500,000 0 0 77,000,000 0 125,000,000          
      other financing activity
    		         0 0 0 -2,457,000 23,406,000 629,000 -1,000 -23,246,000  -6,133,000 -2,481,000 -4,890,000  -114,000 -1,000 -1,927,000    -1,727,000                   
      fair value adjustment on available-for-sale investments
    		     0 0 0 -283,000 681,000                                      
      impairment (recovery) of assets held-for-sale
    		                                               
      net earnings, including noncontrolling interest
    		     40,588,000 49,058,000 27,466,000 50,993,000 75,484,000 70,219,000 50,005,000 89,734,000 61,915,000 60,144,000 72,059,000 68,981,000                               
      contingent consideration payments - operating
    		             0                                  
      loss on equity method investment
    		                                               
      eminence impairment
    		             0 0                                 
      investment of forward purchase contract
    		             0 0                                 
      contingent consideration payments - financing
    		             0                                  
      proceeds from maturities of available-for-sale investments
    		         6,075,000 2,652,000 12,000,000 14,509,000 0 13,605,000 0 12,450,000    29,039,000    11,311,000  11,881,000    0    0 3,930,000  9,880,000 12,681,000 12,561,000 18,103,000 16,090,000 8,116,000 31,665,000 10,721,000 11,601,000 24,763,000 
      investment in unconsolidated entity
    		                 0                              
      investment in wilson wolf
    		         0                                      
      (gain) loss on investment
    		          0 0 -37,176,000                                   
      fair value adjustment on available for sale investments
    		           72,000 -911,000 567,000 18,103,000 -28,395,000 -5,277,000 57,645,000 16,590,000 -10,707,000 4,351,000 -26,260,000 -411,000 -121,257,000 10,401,000 18,974,000 -12,273,000 7,164,000 2,202,000                   
      gain on escrow settlement
    		                                               
      payments on line-of-credit
    		                             -53,500,000 0 85,513,000 -91,513,000 -8,500,000 -1,500,000 -24,500,000  -13,000,000          
      contingent consideration payments
    		               0 -3,300,000 -182,000 0                             
      other investing activity
    		                                               
      net cash provided by investing activities
    		                -7,120,000                               
      net earnings, including non-controlling interest
    		                                               
      change in operating assets and liabilities, net of acquisitions:
    		                                               
      trade accounts payable and accrued expenses
    		                         -1,876,000 2,592,000   3,361,000 6,401,000 -8,868,000 4,132,000 7,561,000 -1,655,000 -416,000 664,000 -1,487,000 793,000 1,569,000 -166,000 -828,000 458,000 -475,000 42,000 218,000 1,598,000 
      proceeds from sale and maturities of available-for-sale investments
    		                 0 23,231,000   24,453,000 54,269,000                         
      purchase of available-for-sale investments
    		                                     0 -17,463,000 -17,406,000 -44,867,000 -27,010,000 -23,613,000 -46,479,000 -21,501,000 -21,119,000 -34,311,000 
      other investing activities
    		                                               
      other financing activities
    		                                               
      cash and cash equivalents at beginning of year
    		                                               
      cash and cash equivalents at end of year
    		                                               
      other current assets
    		                  1,922,000 -3,140,000 1,632,000  70,000 1,229,000 -2,549,000    -1,354,000                   
      re-purchase of common stock
    		                                               
      proceeds from long-term debt
    		                            580,000,000                   
      net increase in cash and cash equivalents
    		                  20,610,000    45,924,000    9,675,000     24,494,000 5,352,000 3,261,000      25,201,000 14,546,000 -79,930,000  7,427,000 12,481,000 14,130,000 1,622,000 
      net decrease in cash and cash equivalents
    		                    22,779,000    -995,000    -27,316,000       -5,690,000  -220,329,000          
      contingent consideration payable
    		                                               
      payment of contingent consideration
    		                                               
      debt issuance costs
    		                            -3,004,000                   
      gain on investment
    		                                               
      excess tax benefit from stock option exercises
    		                                253,000 119,000 -11,000 131,000 -1,007,000 78,000 -262,000 40,000 -36,000 -4,000 -6,000 -5,000 -63,000 -1,000 -7,000 
      payments of contingent consideration
    		                              8,800,000                 
      impairment of investment
    		                                               
      accounts receivable
    		                          -20,984,000                     
      purchases of property and equipment
    		                          -4,925,000    -3,508,000                 
      borrowings under credit agreement
    		                          0                     
      payments on credit agreement
    		                          -23,125,000                     
      other financing
    		                          0    -2,182,000                 
      trade accounts payable, accrued expenses, and contract liabilities
    		                            3,107,000                   
      contingent consideration
    		                                               
      purchase of equity investment
    		                                               
      other
    		                                262,000 -433,000 178,000 26,000 492,000 68,000 168,000 108,000 192,000 124,000 426,000 125,000 105,000 107,000 19,000 
      proceeds from available-for-sale investments
    		                                               
      purchases of available for sale investments
    		                                -6,836,000               
      gain on cyvek acquisition
    		                                               
      net proceeds from maturities and purchases of available-for-sale investments
    		                                               
      distributions from unconsolidated entities
    		                                 0 0 0  446,000          
      gain on sale of cyvek
    		                                               
      net (gain) income from equity method investees
    		                                               
      purchase of common stock for stock bonus plans
    		                                      0 0 0 0 0 0 0 -573,000 -907,000 
      repurchase of common stock
    		                                          -1,821,000 0 0 0 -10,675,000 
      payment on line-of-credit and other
    		                                               
      proceeds from sales of available-for-sale investments
    		                                     0  9,030,000 21,645,000 12,700,000  9,830,000 10,337,000 6,200,000 10,195,000 
      payments on line of credit and other
    		                                               
      impairment losses on investments
    		                                          0     
      increase in other long-term assets
    		                                       -5,000 83,000 -138,000 -151,000 -168,000 -337,000 -87,000 -10,000,000 
      losses by equity method investees
    		                                        0 0  31,000 42,000 41,000 198,000 
      acquisition, net of cash acquired
    		                                        -100,000 -103,049,000      
      distribution from unconsolidated entity
    		                                        0 85,000 1,095,000 0    
      change in operating assets and operating liabilities:
    		                                               
      impairment loss on investments
    		                                               
      increase in other assets
    		                                               
      trade, other accounts payable and accrued expenses
    		                                               
      income taxes payable/receivable
    		                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.